Antinuclear antibodies in children with epilepsy treated by carbamazepine

Epilepsy Research

Volumn 80, Issue 2-3, 2008, Pages 229-230

  Asadi Pooya, Ali Akbar ^a   Asadi Pooya, Kamiar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antinuclear antibody; Carbamazepine; Children; Epilepsy

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBAMAZEPINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CHILD; EPILEPSY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREVALENCE; PRIORITY JOURNAL; URINALYSIS;

ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; MALE;

EID: 47549103102     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.04.004     Document Type: Article

References (4)

1. De Ponti F., Lecchini S., Cosentino M., Castelletti C.M., and Frigo G.M. Immunological adverse effects of anticonvulsants. What is their clinical relevance?. Drug Saf. 8 3 (1993) 235-250
2. Jain K.K. Systemic lupus erythematosus-like syndromes associated with carbamazepine therapy. Drug Saf. 6 5 (1991) 350-360
3. Peltola J.T., Haapala A.M., Isojarvi J.I., et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am. J. Med. 109 (2000) 712-717
4. Ranua J., Luoma K., Peltola J., et al. Anticardiolipin and antinuclear antibodies in epilepsy-a population-based cross-sectional study. Epilepsy Res. 58 1 (2004) 13-18